Catheter-related deep venous thrombosis in children with hemophilia

Citation
Jm. Journeycake et al., Catheter-related deep venous thrombosis in children with hemophilia, BLOOD, 98(6), 2001, pp. 1727-1731
Citations number
25
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
98
Issue
6
Year of publication
2001
Pages
1727 - 1731
Database
ISI
SICI code
0006-4971(20010915)98:6<1727:CDVTIC>2.0.ZU;2-S
Abstract
Central venous catheters (CVCs) are a common adjunct to hemophilia therapy, but the risk of CVC-related deep venous thrombosis (DVT) in hemophiliacs i s not well defined. In a previous study, 13 patients with CVCs had no radio graphic evidence of DVT. However, recent abstracts and case studies demonst rate that DVT does occur. Therefore, this study sought to determine the fre quency of DVT in children with hemophilia and long-term CVCs and to correla te venographic findings with clinical features. All hemophilia patients wit h tunneled subclavian CVCs in place for 12 months or more were candidates f or evaluation. Patients were examined for physical signs of DVT and questio ned about catheter dysfunction. Contrast venograms were obtained to identif y DVT. Fifteen boys with severe hemophilia were evaluated, including 9 from the initially studied group of 13. Eight patients had evidence of DVT, 5 o f whom previously had normal venograms. Five of 15 patients had clinical pr oblems related to the CVC, all of whom had DVT. Four of 15 patients had sug gestive physical signs; 3 had DVT. The mean duration of catheter placement for all patients was 57.5 months (range, 12-102 months). For patients with DVT, the mean duration was 66.6 +/- 7.5 months, compared to 49.5 +/- 7.2 mo nths for patients without DVT (P = .06). No patient whose CVC was in place fewer than 48 months had an abnormal venogram. Many hemophilia patients wit h CVCs develop DVT of the upper venous system, and the risk increases with duration of catheter placement. (C) 2001 by The American Society of Hematol ogy.